Latest Market Expansion News

Page 11 of 91
ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.
Ada Torres
Ada Torres
30 Jan 2026
4DMedical has rapidly commercialised its CT – VQ™ lung imaging technology following FDA clearance, securing major partnerships and regulatory approvals that position it for significant growth in North America.
Ada Torres
Ada Torres
30 Jan 2026
Unith Ltd reports a 17% rise in quarterly cash receipts alongside strategic funding and new technology launches, signalling momentum in its AI-driven digital human platform.
Sophie Babbage
Sophie Babbage
30 Jan 2026
Resonance Health has reported record half-year revenue and strong progress in clinical trials, alongside promising new technology deployments set to enhance its global footprint.
Ada Torres
Ada Torres
30 Jan 2026
TradeWindow reports solid growth in recurring revenue and average revenue per customer but lowers its FY26 trading revenue guidance due to softer transactional volumes in Q3.
Sophie Babbage
Sophie Babbage
30 Jan 2026
Ava Risk Group reports a softer first half with delayed orders impacting revenue, but anticipates a robust recovery in the second half backed by new contracts and a strategic investment.
Sophie Babbage
Sophie Babbage
30 Jan 2026
archTIS Limited reports a remarkable 308% increase in annual recurring revenue, driven by deepening ties with the U.S. Department of Defense and strategic Spirion acquisition integration.
Sophie Babbage
Sophie Babbage
30 Jan 2026
IODM Limited has reported a standout Q2 FY26 with record cash receipts driven by strong UK education sector growth and strategic board renewal.
Sophie Babbage
Sophie Babbage
30 Jan 2026
Terragen Holdings reports a strong quarter with an 87% increase in sales of its ruminant probiotic and advances key livestock and crop trials, positioning itself for expanded market access.
Ada Torres
Ada Torres
30 Jan 2026
The Calmer Co has posted a record $2.01 million in sales for Q2 FY26, propelled by a 9% increase in US revenue which now accounts for over half of the group’s total income. Strong retail and wholesale growth underpin the company’s expanding footprint in the natural relaxation market.
Victor Sage
Victor Sage
30 Jan 2026
The Calmer Co. International Limited has reported a second consecutive quarter of revenue exceeding $2 million, driven by strong U.S. growth and record monthly sales in December. The company’s strategic focus on wholesale and B2B extract channels underpins its confidence in reaching breakeven this fiscal year.
Victor Sage
Victor Sage
30 Jan 2026
Beonic Limited has secured a $7.3 million contract phase for its Moroccan Airports project, completed a $4.27 million capital raise, and fully repaid a $4.65 million USD loan, underpinning its continued EBITDA profitability and positive cash flow.
Sophie Babbage
Sophie Babbage
30 Jan 2026